BriaCell Therapeutics Corp.
Suite 300 – 235 15th Street
West Vancouver, BC V7T 2X1
February 18, 2020
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Division of Corporation Finance
Attention: Abby Adams, Joseph McCann
Re: BriaCell Therapeutics Corp.
Amendment No. 15 to Registration Statement on Form F-1
Filed February 18, 2021
File No. 333-234292
Ladies and Gentlemen:
BriaCell Therapeutics Corp. (the “Company”) is hereby submitting Amendment No. 15 to the Company’s Registration Statement on Form F-1 (“Amendment No. 15”). Amendment No. 15 is being filed solely to increase the total offering amount raised and number of securities offered.
Please do not hesitate to contact me or our counsel with any questions or comments regarding this correspondence or on Amendment No. 15 filed herewith. Thank you.
| Sincerely, | |
| /s/ William V. Williams | |
William V. Williams | |
| Chief Executive Officer |
| cc: | (via email) | ||
| Avital Perlman, Esq. | |||
| Gregory Sichenzia, Esq. |